What is NGAL? The full name of NGAL is human lipocalin 2 (Ln2) or siderocalin. It belongs to the lipocalin family and is the earliest proposed marker of acute kidney injury (AKI). What is the clinical significance of NGAL? 1. NGAL is a marker of acute kidney injury (AKI) When AKI occurs
Figure 1 from Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences
The cellular mechanisms involved in acute kidney injury and its urinary
Acute Kidney Injury
Which Marker Should We Use to Assess Acute Renal Injury - American College of Cardiology
Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Coronary Angiography - Sabah Mohamed Alharazy, Norella Kong, Rashidi Saidin, Abdul Halim Abdul Gafor, Oteh Maskon, Marlyn Mohd, Syed Zulkifli Syed
PDF] Evidence-Based Nephrology Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury
Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury
Proteomic identification of early urinary-biomarkers of acute kidney injury in preterm infants
IJMS, Free Full-Text
Human NGAL Rapid ELISA Kit (KIT 037)
NGAL - Bioporto
First Acute Kidney Injury Diagnostic Test Wins FDA Clearance - Research Horizons
Full article: Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients
Urine neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury and prognosis in decompensated chronic liver disease: A prospective study
